While oral supplements are convenient, their effectiveness can vary due to absorption challenges
It is a triple agonist that activates the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
Localized education, safety messaging and clear referral routes can help patients follow treatment requirements correctly
This receptor belongs to a family called G protein-coupled receptors (GPCRs), specifically the class B1 subfamily
for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
A recent Blue Cross Blue Shield analysis of over 169,000 GLP-1 patients found that 30% quit within the first four weeks , and nearly half dropped off before hitting 12 weeks